Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
ViiV Healthcare
With
Pfizer
This study was cancelled prior to enrollment.
Age
16–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients at least 16 years old with prior extensive treatment experience with limited further options in need of maraviroc to constitute an effective HIV-1 treatment regimen.
Have only CCR5-tropic HIV-1 virus
CD4+ cell count \< 200 cells/mm3
You may not be if
CXCR4- or dual/mixed-tropic HIV-1 virus
Patients who in the opinion of investigator are unlikely to derive benefit from maraviroc as a result of severity of illness
Patients who are pregnant or breast feeding an infant or planning to become pregnant.
